Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-557-4 | CAS number: 84-74-2
Carcinogenicity
Administrative data
Description of key information
DBP is not considered to be carcinogenic to humans.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Additional information
No adequate long-term toxicity and/or carcinogenicity studies in animals or man are available.
Phthalate esters are known to induce peroxisomal proliferation in the liver of mice and rats. In general the longer chain dialkylphthalates are more potent for the induction of peroxisomal proliferation than the shorter chain ones and branched chain phthalates seemed more potent than straight. Many peroxisome proliferators have been shown to induce hepatocellular tumours when administered at high dose-levels for long periods to mice and rats despite being non-genotoxic.
The mechanisms of induction of carcinogenicity by peroxisome proliferators may be complex but are considered to have a threshold. A variety of independent studies have shown that there are marked species differences in the sensitivity to chemicals that cause peroxisome proliferation. Rats and mice are extremely sensitive, hamsters show a less marked response whilst guinea-pigs, primates and man are rather insensitive or non-responsive. (1)
DBP is not considered to be carcinogenic to humans when taking into account that the mechanisms by which DBP and hypolipidaemic substances induce peroxisome proliferation in rodents are not considered relevant to humans, and the absence of evidence associating DBP exposure to carcinogenic effects in humans.(2)
(1)
European Union Risk Assessment Report dibutyl phthalate, Volume 29, p. 16 (2003)
Editors: B. G. Hansen, S.J. Munn, R. A/Ianou, F. Berthault, J. de Bruin, M. Luotamo, C. Musset, S. Pakalin, G. Pellegrini, S. Scheen S. Vegro.
Office for Official Publications of the European Communities, ISBN 92—894—1276—3
(2)
Priority Existing Chemical Assessment Report No. 36, Dibutyl phthalate, November 2013, ISBN 978-0-9874434-4-1, p.84
Australian Government, Department of Health
NATIONAL INDUSTRIAL CHEMICALS NOTIFICATION AND ASSESSMENT SCHEME
GPO Box 58, Sydney NSW 2001 AUSTRALIA www.nicnas.gov.au
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
